Faculty Opinions recommendation of A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.

Author(s):  
Steve Plaxe ◽  
Kristy Ward
2013 ◽  
Vol 130 (3) ◽  
pp. 518-524 ◽  
Author(s):  
Kenneth H. Kim ◽  
Igor P. Dmitriev ◽  
Souheil Saddekni ◽  
Elena A. Kashentseva ◽  
Raymond D. Harris ◽  
...  

2018 ◽  
Vol 24 (10) ◽  
pp. 2285-2293 ◽  
Author(s):  
Daniela Matei ◽  
Sharad Ghamande ◽  
Lynda Roman ◽  
Angeles Alvarez Secord ◽  
John Nemunaitis ◽  
...  

Gene Therapy ◽  
2009 ◽  
Vol 17 (3) ◽  
pp. 360-369 ◽  
Author(s):  
K Anwer ◽  
M N Barnes ◽  
J Fewell ◽  
D H Lewis ◽  
R D Alvarez

2012 ◽  
Vol 23 (3) ◽  
pp. 321-325 ◽  
Author(s):  
Jong Ha Hwang ◽  
Heon Jong Yoo ◽  
Myong Cheol Lim ◽  
Sang-Soo Seo ◽  
Sang-Yoon Park ◽  
...  

1990 ◽  
Vol 36 (3) ◽  
pp. 331-334 ◽  
Author(s):  
Saeeda Kirmani ◽  
Lori McVey ◽  
David Loo ◽  
Stephen B. Howell

Sign in / Sign up

Export Citation Format

Share Document